HYPOGLYCEMIA INDUCED BY ANTIDIABETIC SULFONYLUREAS.
Rev Med Chir Soc Med Nat Iasi
; 119(2): 579-84, 2015.
Article
em En
| MEDLINE
| ID: mdl-26204670
ABSTRACT
Diabetes mellitus is a major health problem due to its increasing prevalence and life-threatening complications. Antidiabetic sulfonylureas represent the first-line drugs in type 2 diabetes even though the most common associated risk is pharmacologically-induced hypoglycemia. In the development of this side effect are involved several factors including the pharmacokinetic and pharmacodynamic profile of the drug, patient age and behavior, hepatic or renal dysfunctions, or other drugs associated with a high risk of interactions. If all these are controlled, the risk-benefit balance can be equal to other oral antidiabetic drugs.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Compostos de Sulfonilureia
/
Diabetes Mellitus Tipo 2
/
Hipoglicemia
/
Hipoglicemiantes
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article